Retrieved from About the Author(s) Rosario Wippold, RN-MPH, is a research nurse, Maher Karam-Hage, MD, and Janice Blalock, PhD, are associate professors in the Department of Behavioral Science, and Paul Cinciripini, PhD, is director of the Tobacco Treatment Program and chair ad interim of the Department of Behavioral Science, all at the University of Texas MD Anderson Cancer Center in Houston
If RAW makes it, we have it
Viral Aromatherapy 510 Cartridge Battery
A determination that a new medical service or technology represents an advance that substantially improves, relative to services or technologies previously available, the diagnosis or treatment of Medicare beneficiaries means ++ The new medical service or technology offers a treatment option for a patient population unresponsive to, or ineligible for, currently available treatments